University of Nebraska Medical Center

DigitalCommons@UNMC
Child Health Research Institute Pediatric
Research Forum

Children’s Hospital & Medical Center

5-5-2022

Maternal and Cord β-Carotene
-Carotene levels and Their Association with
Newborn Hearing Screen Results
O. Paetz
R. Slotkowski
A. Freeman
A. Hergenrader
S. Sweeney

See next page for additional authors

Follow this and additional works at: https://digitalcommons.unmc.edu/chri_forum

Authors
O. Paetz, R. Slotkowski, A. Freeman, A. Hergenrader, S. Sweeney, K. Ali, N. Bender, R. Chaundary, M.
VanOrmer, M. Thompson, M. Thoene, C. Hanson, and A. Anderson-Berry

Maternal and Cord β-Carotene levels and Their Association with Newborn Hearing Screen Results
Paetz O1, Slotkowski R1, Freeman A1, Hergenrader A1, Sweeney S1, Ali K1, Bender N1, Chaundary R1, VanOrmer
M1, Thompson M1, Thoene M1, Hanson C1, Anderson-Berry A1
1 University of Nebraska Medical Center, Omaha NE

Background. β-carotene is one of the few carotenoids that can be endogenously converted to vitamin A, a nutrient
essential for inner ear development. While previous studies have identified a protective effect of carotenoids on
hearing in adults, the impact of β-carotene on hearing outcomes in neonates is not well understood. The purpose of
this study is to investigate the relationship between maternal β-carotene intake, maternal plasma, and umbilical cord
plasma β-carotene levels and abnormal Newborn Hearing Screen (NHS) results.
Significance of Problem. The prenatal period is critical for auditory development; thus, effectors of auditory
development may significantly impact long-term hearing ability. Because maternal nutrition is modifiable, an improved
understanding of the relationship between β-carotene levels and hearing outcomes may be relevant for prenatal care
recommendations.
Hypothesis. We hypothesize that higher levels of β-carotene will be associated with decreased risk of abnormal
NHS results.
Experimental Design. An IRB-approved study enrolled mother-infant pairs (n=541) at the time of delivery. βcarotene plasma levels were analyzed with HPLC. Maternal intake of β-carotene over the past year was quantified
using the validated Harvard Food Frequency Questionnaire. NHS results were obtained from the Electronic Medical
Record. Statistical analysis was done using the Mann-Whitney U and logistic regression tests, with p<0.05
considered statistically significant.
Results. Of the 541 participants, 8.5% of infants had abnormal NHS results. Higher median maternal β-carotene
intake was observed in infants who failed their NHS compared to those who passed (5924 vs. 4722 mcg/day,
p=0.019). Higher median maternal plasma levels of both trans- (206 vs. 149 mcg/L, p=0.021) and cis-β-carotene
(15.9 vs. 11.2 mcg/L, p=0.015) were observed in infants who failed their NHS. Higher median cord plasma trans βcarotene was observed in infants who failed their NHS (15.5 vs. 8.0 mcg/L, p=0.04). Associations between failed
NHS and log-transformed β-carotene intake and serum levels remained in a logistic regression model after
adjustment for NICU admission, race/ethnicity, smoking status, maternal age, corrected gestational age, infant sex,
and log transformed maternal caloric intake.
Conclusion. The observed relationship between higher β-carotene levels and abnormal NHS was unexpected. While
other studies suggest both deficient and excessive levels of vitamin A can impact inner ear development, β-carotene
levels in our study were not exceptionally high. One possible explanation is that higher maternal β-carotene levels
may be indicative of impaired transfer of β-carotene to the fetus. Further study is warranted to better understand the
relationship between β-carotene and NHS results.

